- First Hemp CBD brand to enter Latin American market under
Dixie Brands joint venture
- Builds on proven Aceso brand acceptance across US consumer
market
- Product line includes indication-specific (heat and cool),
hemp-derived CBD balms
- Approval secured from INVIMA for commercialization in
Colombia of initial Aceso
products, Alfa Balm (heat) and Sigma Balm (cool)
- Introduction to Colombian market in Q4 2019 with expansion to
Chile and Uruguay in 2020
- Latin America
herbal/traditional topical analgesic and topical
analgesics/Anaesthetic market estimated at US$380 million (Source: Euromonitor 2018)
- Strong corporate balance sheet positions Company to take full
advantage of LatAm market demand for CBD consumer products
TORONTO, Nov. 11, 2019 /CNW/ - Khiron Life Sciences
Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB:
KHRNF), (Frankfurt: A2JMZC), a
vertically integrated cannabis leader with core operations in
Latin America, announced today
that the Company will introduce the Aceso™ Hemp brand to the
Latin America market, with initial
sales beginning in Q4 2019 in Colombia. Aceso Hemp, which is part of
the Dixie Brands family of products,
produces a line of innovative balms for the growing hemp-based
consumer wellness market, and is widely established in the US
market. Aceso represents the first brand to enter the Latin America market under the Company's joint
venture with Dixie Brands Inc. (CSE: Dixi.U).
Aceso Hemp is the next generation in hemp, pairing plant science
with food science. Offering a growing line of indication-specific,
hemp-derived supplements for promoting optimal health, Aceso Hemp
was one of the first entrants in the category and brings a deep
understanding of the industry's complex regulatory structure and
expertise in the production of safe, effective and compliant
products that can be sold across the
United States. Aceso Hemp's scientists have studied, tested
and perfected phyto-nutrient ratios that unlock the powers of hemp,
resulting in sophisticated formulas that are easy for the body to
absorb and activate.
With its market-leading knowledge of the Latin American market
Khiron will initially prioritize two Aceso products for
commercialization in the Colombian market. Aceso Alfa Balm and
Aceso Sigma Balm blend essential oils and ingredients to soothe
aching muscles and revitalize skin, and enhance their impact with
broad-based hemp. Each product contains 56 mg of naturally
occurring cannabinoids.
Alvaro Torres, Khiron CEO and
Director, commented, "Khiron is one of very few cannabis companies
with the cash reserves to continue to aggressively expand its
business operations. Our strong balance sheet and proven
operational team positions us to further take advantage of the
tremendous market demand that we see for CBD consumer products in
the LatAm region. The introduction of the Aceso brand, the first
from our joint venture with Dixie
Brands, positions us to build on the brands already wide
adoption in the US and translate that through our establish retail
network to consumers in Latin
America."
The launch of Aceso into Colombia continues the Company's strategy to
bring innovative CBD-based cosmeceutical and wellness products to
the Latin American market. In 2018 the Company launched Kuida, a
comprehensive line of skincare products which are now sold across
Colombia, are set to launch in the
US and have received approval for commercialization in the UK.
Michael McMahon, Dixie's General
Manager of Latin America, added,
"We are excited to see our joint venture with Khiron starting to
yield the opportunities to introduce our products into the market.
This is the tip of the iceberg, and as we continue to refine our
products to meet the regulatory requirements in each country, we
will be expanding into more countries and delving deeper into our
product portfolio."
About Dixie Brands,
Inc.
Dixie Brands Inc., through its licensed partners, has been
formulating award-winning THC and CBD-infused products since
2009. Currently operating in five U.S. states, the Company is
expecting to double its manufacturing and distribution capabilities
in 2019 in the U.S. as well as expand internationally, including
Canada and Latin America. Dixie leads the global industry
in the development, packaging design, product innovation and
quality control for the commercial production of cannabis infused
products. While the Company started with a single flagship product,
the Dixie Elixir (a THC-infused soda), it is now one of the
industry's most recognized consumer brands, expanding to over 100
products across more than 15 different product categories
representing the industry's finest edibles, tinctures, topicals and
connoisseur grade extractions, as well as world-class CBD-infused
wellness products and pet dietary supplements. Dixie's executive
team has been instrumental in the formation of the marijuana
industry for recreational and medicinal use, serving as founding
members on several national regulatory and business-oriented
industry organizations.
About Khiron Life Sciences Corp.
Khiron Life Sciences
Corp. is positioned to be the dominant integrated cannabis company
in Latin America. Khiron has core
operations in Latin America and is
fully licensed in Colombia for the
cultivation, production, domestic distribution, and international
export of both tetrahydrocannabinol (THC) and cannabidiol (CBD)
medical cannabis. The company delivers best in class regulatory
compliance, has the first approved set of CBD cosmetic products on
shelf in Colombia, and is currently facilitating testing to
meet and surpass all license requirements for commercial cannabis
derived products.
With a focused regional strategy and patient oriented
approach, the Company combines global scientific expertise,
agricultural advantages, branded product market entrance
experience and education to drive prescription and brand
loyalty to address priority medical conditions such as chronic
pain, epilepsy, depression and anxiety in the Latin American
market of over 620 million people. The Company is led by Co-founder
and Chief Executive Officer, Alvaro
Torres, together with an experienced executive team,
and a knowledgeable Board of Directors that includes former
President of Mexico, Vicente Fox.
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Khiron undertakes no obligation to comment analyses,
expectations or statements made by third-parties in respect of
Khiron, its securities, or financial or operating results (as
applicable). Although Khiron believes that the expectations
reflected in forward-looking statements in this press release are
reasonable, such forward-looking statement has been based on
expectations, factors and assumptions concerning future events
which may prove to be inaccurate and are subject to numerous risks
and uncertainties, certain of which are beyond Khiron's control,
including the risk factors discussed in Khiron's Annual Information
Form which is available on Khiron's SEDAR profile
at www.sedar.com. The forward-looking information contained in
this press release is expressly qualified by this cautionary
statement and are made as of the date hereof. Khiron disclaims any
intention and has no obligation or responsibility, except as
required by law, to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise.
United States Disclaimer
This news release does not constitute an offer to sell or a
solicitation of an offer to buy any of the securities
in the United States. The securities have not been and
will not be registered under the United States Securities Act of
1933, as amended (the "U.S. Securities Act") or any state
securities laws and may not be offered or sold within the
United States or to U.S. Persons
(as such term is defined in Regulation S under the U.S. Securities
Act) unless registered under the U.S. Securities Act and applicable
state securities laws or an exemption from such registration is
available.
Neither the TSXV nor its Regulation Services Provider (as
that term is defined in the policies of the TSXV) accepts
responsibility for the adequacy or accuracy of this press
release.
Further information in respect of the Company can be found
at www.khiron.ca.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/khiron-receives-approval-to-sell-aceso-hemp-cbd-brand-in-colombia-300955241.html
SOURCE Khiron Life Sciences Corp.